Biopharma Journey to AI, powered by Realtime PAT & Advanced Analytics

発表要旨

The biomanufacturing industry is evolving from a standard batch processing paradigm to a more continuous operation supported by in-line sensors and process analytics to enable real-time product release. Data driven continuous operations will help to significantly improve product quality, reduce production costs, shorten the time to market and requires addressing the technical challenges such as flexible control & automation strategies capable of adjusting critical process parameters (CPPs) in real time to achieve stable critical quality attributes (CQAs) and end-to-end data collection capabilities with real-time monitoring enabled. Companies tackle these technical challenges by leveraging data. These include artificial intelligence, and advanced analytics. To benefit from all those promises of AI, manufacturers need to learn how to maximize the utilization of the datasets already at their disposal and identify, access, and integrate new data sources.

In Bioprocessing 4.0, the wide range of data is an important source for scientific understanding, and speeding up data acquisition to analysis, then control is essential, the real time monitoring and smart data management are expected to push boundaries and unlocking unprecedented possibilities to transform drug manufacturing. In this presentation, I would highlight the current challenges of bioprocessing data utilization and introduce the solution for the data aggregation, management, visualizations, and statistical analysis, and demonstrates the benefits of smart data management by Bio4C™ ProcessPad and real time monitoring of ProCellics™ Raman analyzer. In this talk I would also put emphasis on how can companies leverage the power of smart data for AI adoption in continuous biomanufacturing.

プロフィール

Hemant Garg is on a digital mission to help the biopharmaceutical industry grow and evolve in a data-driven world. Trained as a business analytics biotechnology engineer, he has 14 years’ professional experience working across multiple roles within biopharma manufacturing. Hemant’s expertise in complex industry research, long-term forecasting, data analytics and process modeling enable him to identify, create, and capitalize on unmet market needs. At Merck Life Science, Hemant leads the strategy and launch of digital and analytics products for biopharmaceutical customers and is presently working as a Product Manager Analytics in Integrated Solution Marketing, Biocontinuum Platform.